Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498993 | 12549899 | 3 | F | 201604 | 20160815 | 20160712 | 20160819 | EXP | US-PFIZER INC-2016335536 | PFIZER | 79.00 | YR | F | Y | 75.00000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498993 | 12549899 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, DAILY (EVERY MORNING) | 20753 | 25 | MG | COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125498993 | 12549899 | 1 | Breast cancer recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125498993 | 12549899 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125498993 | 12549899 | Clostridium difficile colitis | |
| 125498993 | 12549899 | Diarrhoea | |
| 125498993 | 12549899 | Diverticulitis | |
| 125498993 | 12549899 | Gastric infection | |
| 125498993 | 12549899 | Polyp |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125498993 | 12549899 | 1 | 201602 | 0 |